Shanghai Dunwill Medical Technology Development Co.
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- Undisclosed
Investors
- 5
About Shanghai Dunwill Medical Technology Development Co.
, Ltd. is a medical technology company that focuses on the research and development of tumor and metabolic disease diagnostic products. The founder of the company is Dong Wen. The company's main products include microRNA (miRNA) early diagnosis of liver cancer, circulating tumor cells (CTC) early warning of liver cancer metastasis and recurrence, and liver cancer patient-derived tissue transplantation models (PDX) to guide targeted therapy.
Who invested in Shanghai Dunwill Medical Technology Development Co.
5 investors across 1 round
See all investors in Shanghai Dunwill Medical Technology Development Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 1, 2022
Amount
Undisclosed
Investors
Questions about Shanghai Dunwill Medical Technology Development Co.
Who invested in Shanghai Dunwill Medical Technology Development Co.?
Shanghai Dunwill Medical Technology Development Co. has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Dunwill Medical Technology Development Co. raised?
Shanghai Dunwill Medical Technology Development Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shanghai Dunwill Medical Technology Development Co. last raise money?
Shanghai Dunwill Medical Technology Development Co.'s most recent round on record is a Series A, in Jun 2022.
What does Shanghai Dunwill Medical Technology Development Co. do?
Shanghai Dunwill Medical Technology Development Co. is a biotechnology company.
Where is Shanghai Dunwill Medical Technology Development Co. headquartered?
Shanghai Dunwill Medical Technology Development Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Dunwill Medical Technology Development Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai Dunwill Medical Technology Development Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Shanghai Dunwill Medical Technology Development Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.